about
Global shape and ligand binding efficiency of the HIV-1-neutralizing antibodies differ from those of antibodies that cannot neutralize HIV-1Global structure of HIV-1 neutralizing antibody IgG1 b12 is asymmetricStructural Analysis of the Myo1c and Neph1 Complex Provides Insight into the Intracellular Movement of Neph1SAXS data analysis and modeling of tetravalent neutralizing antibody CD4-IgG2 -/+ HIV-1 gp120 revealed that first two gp120 bind to the same Fab arm.Evidence on how a conserved glycine in the hinge region of HapR regulates its DNA binding ability: lessons from a natural variantAdriamycin susceptibility among C57BL/6 substrains.Carrier protein influences immunodominance of a known epitope: implication in peptide vaccine design.Targeting Neph1 and ZO-1 protein-protein interaction in podocytes prevents podocyte injury and preserves glomerular filtration function.A Novel CLCN5 Mutation Associated With Focal Segmental Glomerulosclerosis and Podocyte Injury.Development of a novel cell-based assay to diagnose recurrent focal segmental glomerulosclerosis patientsMitochondrial biogenesis induced by the β2-adrenergic receptor agonist formoterol accelerates podocyte recovery from glomerular injuryDisruption of the exocyst induces podocyte loss and dysfunctionThe motor protein Myo1c regulates transforming growth factor-β-signaling and fibrosis in podocytesThe Use of High-Throughput Transcriptomics to Identify Pathways with Therapeutic Significance in PodocytesMutations in KIRREL1, a slit diaphragm component, cause steroid-resistant nephrotic syndromeA Functional Binding Domain in the Rbpr2 Receptor Is Required for Vitamin A Transport, Ocular Retinoid Homeostasis, and Photoreceptor Cell Survival in Zebrafish
P50
Q28250040-FF40C90C-A0AB-46DA-9916-131833FE6773Q28267044-472E304A-8862-4294-BFAC-DD5118534EC2Q30788904-6B661FA1-B861-459E-84AA-EAFD6A3E827FQ34073364-62282F29-EF54-4422-BD36-C9B1A954AF32Q34869190-E5F022F8-699E-4239-AA50-5EA3CE91597CQ41025123-11BFC668-7E1C-4603-AF81-75D35DD75B5DQ42251848-7C5B5540-0E77-462A-940F-EB10508F5963Q42362352-100DAED6-2DC8-4637-9C00-31763C5045B3Q64983760-419000DC-FE92-4C21-AB7A-E0512D89733EQ91311087-FCB90E49-360E-4A9D-AF41-4D9F17CCDF9AQ91524031-EC626061-7972-4EE1-8A6D-5F05597FA04CQ91898471-F258E439-DCCB-45CA-9361-1EB17FBA5748Q92087867-D73B34DC-8D03-4D9A-A1D7-78A0EF8B5127Q92445005-12DCA8A8-F45F-4447-98ED-649BC5FA0FD2Q93033789-E99400E1-4A90-4732-BF16-B73A17004F8AQ94514015-7C5B3AAD-F207-4758-B970-8B5AF374377A
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Ashish K Solanki
@en
Ashish K Solanki
@nl
type
label
Ashish K Solanki
@en
Ashish K Solanki
@nl
prefLabel
Ashish K Solanki
@en
Ashish K Solanki
@nl
P31
P496
0000-0002-5043-1699